Skip to main content
. 2014 Mar 19;105(5):600–607. doi: 10.1111/cas.12382

Figure 3.

Figure 3

Disease-free (a) and breast cancer-specific survival (b–e) of stage I–III patients according to GATA4 status. The solid line shows GATA4-positive cases and the dashed line shows GATA4-negative cases. (a, b) Total cases (= 140); (c) cases negative for lymph node metastasis (= 89); (d) estrogen receptor (ER)-positive cases that received adjuvant endocrine therapy following surgery (= 81); and (e) cases that received adjuvant chemotherapy after surgery (= 95). Statistical analysis was performed using the log-rank test. P-values < 0.05 were considered significant and are shown in bold.